Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods - Ainsworth Dental Company Pty Ltd - 158797

Overview

The Therapeutic Goods Act 1989, enacted by the Parliament of Australia, serves to regulate the provision of therapeutic goods within the country, ensuring public safety and quality. This Act was introduced to address the need for a robust framework governing the manufacturing, supply, and regulation of therapeutic goods, including medical devices, to protect consumers from substandard and unsafe products. Within this legislative context, the publication of the cancellation of entries for kinds of medical devices from the Australian Register of Therapeutic Goods is a critical function aimed at maintaining the integrity and safety of the medical device market. The policy objective underpinning this specific action is to uphold the standards for medical device safety and efficacy by removing entries that do not comply with the required certifications and conformity assessment procedures. This measure ensures that only those medical devices meeting the necessary health and safety standards are available for use in Australia, thereby safeguarding public health.

Scope and Application

The Therapeutic Goods Act 1989 (TGA) applies to a broad range of stakeholders, including individuals and entities engaged in the manufacture, supply, and advertising of therapeutic goods, which encompass medicines, medical devices, blood, and tissues. The scope of the TGA extends to the entire Commonwealth of Australia, ensuring a uniform regulatory framework across the nation. The Act governs the regulation of therapeutic goods from their development and clinical trials through to manufacturing, importation, supply, and advertising, with specific focus on ensuring the quality, safety, and efficacy of these goods. The TGA mandates that medical devices be included in the Australian Register of Therapeutic Goods (ARTG), and it is within this regulatory context that the cancellation of entries is managed. Certain exclusions and exemptions exist, particularly for goods that are subject to other specific legislative regimes or are intended for research purposes. The Act's application can also be extended or restricted through subordinate instruments, allowing for detailed regulatory measures to be specified for particular types of therapeutic goods or industry practices. The cancellation of a specific entry, such as the reusable dental suction cannula listed under ARTG number 158797, is a clear example of the Act's enforcement powers being exercised to maintain the integrity of the ARTG.

Key Provisions

The primary operative sections of the Gazette, C2012G00011, concern the cancellation of entries for specific kinds of medical devices from the Australian Register of Therapeutic Goods (ARTG). This notice, issued under section 41GP of the Therapeutic Goods Act 1989, outlines the cancellation of an entry for a particular type of medical device, namely a reusable dental suction cannula (subsection 41GN(1)(f)). The Gazette specifically identifies the entry number (158797), the sponsor (Ainsworth Dental Company Pty Ltd), and the manufacturer (Hager & Werken GmbH & Co KG from Germany). The cancellation is effective as of 22 October 2012, following the date of the notice, 19 September 2012. The reason for the cancellation is provided as inaccuracies in the certifications regarding the device's classification and the conformity assessment procedures applied. The Act imposes obligations on the parties involved, particularly the sponsor and the manufacturer, to ensure that all certifications made in applications to include a kind of device in the ARTG are accurate and compliant with the relevant regulatory requirements. The sponsor, Ainsworth Dental Company Pty Ltd, and the manufacturer, Hager & Werken GmbH & Co KG, must have provided correct information about the classification and conformity assessment procedures applied to the dental suction cannula. Failure to meet these obligations can lead to the cancellation of the ARTG entry, as demonstrated in this Gazette. Breaches of the obligations outlined in the Therapeutic Goods Act 1989 may result in civil or criminal penalties. While the Gazette does not specify particular penalties for this instance, the Act generally provides for substantial fines and, in serious cases, imprisonment. The Act empowers the Secretary to the Department of Health and Ageing to take action against non-compliance, including the cancellation of ARTG entries and the imposition of penalties as stipulated under the Act. The specific penalties for breaches are detailed in other sections of the Act and can vary based on the severity and intent behind the non-compliance.